Research Studies
Back to Results
Effects of pubertal blockade and hormone therapy on cardiometabolic risk markers in transgender adolescents
Description
There will be 6 study visits over about a year. They will take place over 2 days before starting testosterone and then 1 month and 12 months after starting testosterone. The first study visit will involve a blood draw, an oral glucose tolerance test (sugar drink) and answering questionnaires. The second day will involve an ultrasound of the arteries in the arm, abdominal MRI, exercise bike test and a body scan to evaluate fat and bone density. Participants will wear a sleep and activity monitor for a week after the second visit day.
MoreDetails
Age
Child
Eligibility
Age 13-16 years, going to start testosterone within the next 6 months
Detailed Eligibility: Cannot be on a medication containing estrogen or progesterone or on an antipsychotic medication.
Phase
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Type of Study
Observational
Locations
Childrens Hospital Colorado
University of Colorado Hospital
Principal Investigator
Natalie Nokoff, MD
Study ID
Protocol Number: 17-2328
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers